Autoimmunity to Bile Duct Epithelial Cells in Patients with Primary Billary Cirrhosis

原发性胆汁性肝硬化患者胆管上皮细胞的自身免疫

基本信息

  • 批准号:
    62570329
  • 负责人:
  • 金额:
    $ 1.02万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1987
  • 资助国家:
    日本
  • 起止时间:
    1987 至 1988
  • 项目状态:
    已结题

项目摘要

Primary biliary cirrhosis (PBC) is an enigmatic chronic liver disease characterized by progressive and inflammatory obliteration of intrahepatic bile ducts where autoimmune-mediated pathogenesis is considered to be responsible for damages to the target tissue. We reported a predominant role of T cell mediated immunity in the pathogenesis of PBC, because peripheral lymphocytes were sensitized to partially purified biliary antigen in leukocyte migration inhibition test, while antibody to the same antigen was not detected in the sera of PBC patients.In this study, histoimmunochemical investigation showed that OKT8 positive and Leul5 negative T cell population, phenotypically cytotoxic T cells infiltrated into damaged bile ducts in PBC. Furthermore, splenic T lymphocytes but not non-T lymphocytes were shown to be cytotoxic against autologous biliary epithelial( BE ) cells at effector to target ratios of 100 and 200 in 10hrs'^<51>Cr% release. BE cells were obtained from autopsy specimen by … More pumping PBS solution supplemented with EDTA, DNAase and Disparse into bile ducts. Specificity of cytotoxicity was shown by cold target inhibition using autologous BE cells. A phenotype of effectors was shown to be CD8 positive by negative selection using complement lysis with OKT8 or OKT4 monoclonal antibody. Next, biliary epithelial antigens were identified by SDS-PAGE and Western blotting of partially purified biliary antigen in which rabbit anti-biliary antigen specific to human biliary epithelial cells was used to detect the antigens. B1, B2 and B3 antigens with more than 200 KD mw were detected. They were eluted electophoretically from gels separately and used as antigens to stimulate T cell proliferation. Blastgensis to B1 at a constriction of 1.0 to 0.1 mc g/ml was detected exclusively in PBC but not in other liver diseases while blastgenesis to B3 was not detected in PBC.These data strongly point to the role of T cell immunity against biliary epithelial antigen; B1 antigen in the pathogenesis of PBC. Less
原发性胆汁性肝硬化(PBC)是一种以肝内胆管进行性炎症性闭塞为特征的慢性肝病,其自身免疫介导的发病机制被认为是导致靶组织损伤的原因。我们报道了T细胞介导的免疫在PBC发病中的主导作用,因为外周血淋巴细胞在白细胞移动抑制试验中对部分纯化的胆汁抗原敏感,而PBC患者血清中未检测到针对相同抗原的抗体。PBC中表型细胞毒性T细胞浸润到受损的胆管中。此外,脾T淋巴细胞而非非T淋巴细胞显示出在10小时的μ Cr%释放中在100和200的效应与靶比下对自体胆管上皮(BE)细胞具有细胞毒性<51>。BE细胞从尸检标本中获得, ...更多信息 将补充有EDTA、DNAase和Disparse的PBS溶液泵入胆管。使用自体BE细胞通过冷靶抑制显示细胞毒性的特异性。通过使用OKT 8或OKT 4单克隆抗体进行补体裂解的阴性选择,显示效应子的表型为CD 8阳性。接着,通过部分纯化的胆汁抗原的SDS-PAGE和Western印迹鉴定胆汁上皮抗原,其中使用对人胆汁上皮细胞特异性的兔抗胆汁抗原来检测抗原。检测到分子量大于200 KD的B1、B2和B3抗原。它们分别从凝胶电泳洗脱并用作刺激T细胞增殖的抗原。在1.0 ~ 0.1mcg/ml的收缩中,PBC仅检测到B_1的胚细胞生成,而在其他肝病中未检测到B_3的胚细胞生成。这些数据有力地指出了T细胞对胆管上皮抗原、B_1抗原的免疫在PBC发病中的作用。少

项目成果

期刊论文数量(21)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
中田文子,前田隆 他: 肝臓. 28. 1331-1339 (1987)
Fumiko Nakata、Takashi Maeda 等:肝脏。28. 1331-1339 (1987)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
西原利治,大西三朗 他: 消化器と免疫. 20. 103-105 (1988)
Toshiharu Nishihara、Saburo Onishi 等:胃肠系统和免疫。20. 103-105 (1988)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Onshi Saburo; Ito Kenichi: "JIkomenekisei Kanshikkan" Nifon Rinsho. 46. 936-941 (1988)
恩志三郎;
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
山本泰朗,大西三朗,伊藤憲一: "肝疾患研究の進歩II:PBCにおけるOverlapping疾候群" メディカルレビュー社, 137-146 (1988)
Yasuo Yamamoto、Saburo Onishi、Kenichi Ito:“肝病研究进展 II:PBC 重叠综合征”Medical Review Company,137-146 (1988)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
大西三朗,伊藤憲一: 日本臨床. 46. 936-941 (1988)
Saburo Onishi,Kenichi Ito:日本临床实践 46. 936-941 (1988)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ONISHI Saburo其他文献

ONISHI Saburo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ONISHI Saburo', 18)}}的其他基金

Primary biliary cirrhosis and estrogen-mediated regulation of CD4+CD25+ thymocyte differentiation.
原发性胆汁性肝硬化和雌激素介导的 CD4 CD25 胸腺细胞分化调节。
  • 批准号:
    15590657
  • 财政年份:
    2003
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Modulation of thymocyte development by estrogen and autoimmune hepatitis
雌激素对胸腺细胞发育的调节和自身免疫性肝炎
  • 批准号:
    13670525
  • 财政年份:
    2001
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
PRES1 CONTRIBUTES IN HEPATOCARCINOGENESIS IN PATIENTS WITH HBV INFECTION
PRES1 有助于 HBV 感染患者的肝癌发生
  • 批准号:
    11670510
  • 财政年份:
    1999
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Autoimmune-mediated mechanism of biliary injury in primary biliary cirrhosis
原发性胆汁性肝硬化中自身免疫介导的胆道损伤机制
  • 批准号:
    07457596
  • 财政年份:
    1995
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
T cell immunity to biliary epithelial antigen in primary biliary cirrhosis.
原发性胆汁性肝硬化中 T 细胞对胆道上皮抗原的免疫。
  • 批准号:
    04670433
  • 财政年份:
    1992
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Purification of Human Biliary Epithelial Antigen and T Cell Autoimmunity in Patients with Primary biliary Cirrchosis
原发性胆汁性肝硬化患者人胆管上皮抗原的纯化及T细胞自身免疫
  • 批准号:
    01570404
  • 财政年份:
    1989
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
  • 批准号:
    10581488
  • 财政年份:
    2022
  • 资助金额:
    $ 1.02万
  • 项目类别:
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
  • 批准号:
    10332251
  • 财政年份:
    2022
  • 资助金额:
    $ 1.02万
  • 项目类别:
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
  • 批准号:
    444149
  • 财政年份:
    2021
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Operating Grants
Utilizing intranasal immunization to induce a cytotoxic T lymphocyte response and reduce metastatic burden in the lung
利用鼻内免疫诱导细胞毒性 T 淋巴细胞反应并减少肺转移负担
  • 批准号:
    10090666
  • 财政年份:
    2020
  • 资助金额:
    $ 1.02万
  • 项目类别:
Re-sensitization of immune checkpoint therapy resistant cancers to cytotoxic T-lymphocyte mediated killing
免疫检查点疗法耐药性癌症对细胞毒性 T 淋巴细胞介导的杀伤重新敏感
  • 批准号:
    412967
  • 财政年份:
    2019
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Fellowship Programs
Mechanism for control of HIV-1 by cytotoxic T lymphocyte
细胞毒性T淋巴细胞控制HIV-1的机制
  • 批准号:
    17K10021
  • 财政年份:
    2017
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Understanding the regulation of cytotoxic T lymphocyte signalling and activity through single-cell genomics
通过单细胞基因组学了解细胞毒性 T 淋巴细胞信号传导和活性的调节
  • 批准号:
    MR/P014178/1
  • 财政年份:
    2017
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Fellowship
Enhancing cytotoxic T lymphocyte (CTL) responses by directly loading CTL epitope vaccines onto MHC Class I complexes on the dendritic cell surface
通过将 CTL 表位疫苗直接负载到树突状细胞表面的 MHC I 类复合物上,增强细胞毒性 T 淋巴细胞 (CTL) 反应
  • 批准号:
    9299648
  • 财政年份:
    2017
  • 资助金额:
    $ 1.02万
  • 项目类别:
Discovery of Cytotoxic T Lymphocyte-inspired Bacteria Machine for Cancer Therapeutic Use Based on Synthetic Biological Approach
基于合成生物学方法发现细胞毒性 T 淋巴细胞启发的用于癌症治疗的细菌机器
  • 批准号:
    15K14415
  • 财政年份:
    2015
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Elucidation of molecular mechanism of SV40 VP1 capsid protein to induce aimed cytotoxic T lymphocyte against viruses and its application for vaccine formulation.
阐明SV40 VP1衣壳蛋白诱导针对病毒的细胞毒性T淋巴细胞的分子机制及其在疫苗制剂中的应用。
  • 批准号:
    26860112
  • 财政年份:
    2014
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了